{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T18:47:50Z","timestamp":1792176470515,"version":"4.4.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Complementary Therapies in Medicine"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.ctim.2016.10.014","type":"journal-article","created":{"date-parts":[[2016,11,17]],"date-time":"2016-11-17T15:15:12Z","timestamp":1479395712000},"page":"36-39","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Hypericum perforatum (St. John\u2019s Wort) as a possible therapeutic alternative for the management of trigeminal neuralgia (TN) \u2013 A case report"],"prefix":"10.1016","volume":"30","author":[{"given":"Khalil","family":"Assiri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yagoub","family":"Alyami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James M.","family":"Uyanik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcela","family":"Romero-Reyes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ctim.2016.10.014_bib0005","series-title":"Classification of Chronic Pain: Descriptions of Chronic Pain Syndromes and Definitions of Pain Terms","first-page":"59","author":"Merskey","year":"1994"},{"key":"10.1016\/j.ctim.2016.10.014_bib0010","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1159\/000110284","article-title":"Epidemiology and clinical features of idiopathic trigeminal neuralgia and glossopharyngeal neuralgia: similarities and differences, Rochester, Minnesota, 1945\u20131984","volume":"10","author":"Katusic","year":"1991","journal-title":"Neuroepidemiology"},{"issue":"Pt 4","key":"10.1016\/j.ctim.2016.10.014_bib0015","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1093\/brain\/123.4.665","article-title":"The incidence and lifetime prevalence of neurological disorders in a prospective community-based study in the UK","volume":"123","author":"MacDonald","year":"2000","journal-title":"Brain"},{"issue":"suppl. 1","key":"10.1016\/j.ctim.2016.10.014_bib0020","first-page":"9","article-title":"The international classification of headache disorders","volume":"24","author":"Headache Classification Subcommittee of the Interna- tional Headache Society","year":"2004","journal-title":"Cephalalgia"},{"issue":"15","key":"10.1016\/j.ctim.2016.10.014_bib0025","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1212\/01.wnl.0000326598.83183.04","article-title":"Practice Parameter: the diagnostic evaluation and treatment of trigeminal neuralgia (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology and the European Federation of Neurological Societies","volume":"71","author":"Gronseth","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.ctim.2016.10.014_bib0030","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1129-2377-15-34","article-title":"Natural history and outcome of 200 outpatients with classical trigeminal neuralgia treated with carbamazepine or oxcarbazepine in a tertiary centre for neuropathic pain","volume":"15","author":"Di Stefano","year":"2014","journal-title":"J Headache Pain"},{"issue":"6","key":"10.1016\/j.ctim.2016.10.014_bib0035","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1177\/2042098613499791","article-title":"The risk of cutaneous adverse reactions among patients with the HLA-A* 31:01 allele who are given carbamazepine, oxcarbazepine or eslicarbazepine: a perspective review","volume":"4","author":"Kaniwa","year":"2013","journal-title":"Therap Adv Drug Saf"},{"issue":"1","key":"10.1016\/j.ctim.2016.10.014_bib0040","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1129-2377-15-34","article-title":"Natural history and outcome of 200 outpatients with classical trigeminal neuralgia treated with carbamazepine or oxcarbazepine in a tertiary centre for neuropathic pain","volume":"15","author":"Di Stefano","year":"2014","journal-title":"J Head Pain"},{"issue":"2","key":"10.1016\/j.ctim.2016.10.014_bib0045","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s40263-012-0023-0","article-title":"Refractory trigeminal neuralgia. Non-surgical treatment options","volume":"27","author":"Cruccu","year":"2013","journal-title":"CNS Drugs"},{"issue":"6","key":"10.1016\/j.ctim.2016.10.014_bib0050","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1177\/0333102412441721","article-title":"Botulinum toxin type A for the treatment of trigeminal neuralgia: results from a randomized, double-blind, placebo-controlled trial","volume":"32","author":"Wu","year":"2012","journal-title":"Cephalalgia"},{"key":"10.1016\/j.ctim.2016.10.014_bib0055","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/1129-2377-15-43","article-title":"Therapeutic effect of Botulinum toxin-A in 88 patients with trigeminal neuralgia with 14-month follow-up","volume":"15","author":"Li","year":"2014","journal-title":"J Head Pain"},{"issue":"3","key":"10.1016\/j.ctim.2016.10.014_bib0060","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.aorn.2015.01.013","article-title":"Considerations for complementary and alternative interventions for pain","volume":"101","author":"Schulenburg","year":"2015","journal-title":"AORN J"},{"key":"10.1016\/j.ctim.2016.10.014_bib0065","series-title":"Discovering Homeopathy","first-page":"4","author":"Ullman","year":"1993"},{"issue":"1","key":"10.1016\/j.ctim.2016.10.014_bib0070","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.cden.2006.09.008","article-title":"Complementary and alternative medicine for persistent facial pain","volume":"51","author":"Myers","year":"2007","journal-title":"Dent Clin North Am"},{"key":"10.1016\/j.ctim.2016.10.014_bib0075","series-title":"Discovering Homeopathy","first-page":"4","author":"Ullman","year":"1993"},{"key":"10.1016\/j.ctim.2016.10.014_bib0080","first-page":"230","article-title":"The future of natural healing","volume":"25\u201341","author":"Thomas","year":"2011","journal-title":"Marion, MA: Marion Institute: Biol Med"},{"key":"10.1016\/j.ctim.2016.10.014_bib0085","unstructured":"Medicine, N.I.o.H.N.C.f.C.a.A. Homeopathy: An Introduction: 2016 April 2016; Available from: http:\/\/nccam.nih.gov\/health\/homeopathy."},{"issue":"6772","key":"10.1016\/j.ctim.2016.10.014_bib0090","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1136\/bmj.302.6772.316","article-title":"Clinical trials of homoeopathy","volume":"302","author":"Kleijnen","year":"1991","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.ctim.2016.10.014_bib0095","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.homp.2015.12.012","article-title":"A retrospective cohort study on the efficacy of homeopathy compared to homeopathy plus conventional medicine in the treatment of hypertension","volume":"105","author":"Phing","year":"2016","journal-title":"Homeopathy"},{"issue":"1","key":"10.1016\/j.ctim.2016.10.014_bib0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2046-4053-3-142","article-title":"Randomised placebo-controlled trials of individualised homeopathic treatment: systematic review and meta-analysis","volume":"3","author":"Mathie","year":"2014","journal-title":"Syst Rev"},{"issue":"3","key":"10.1016\/j.ctim.2016.10.014_bib0105","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1001\/jama.2016.9400","article-title":"Comparison of clinical outcomes and adverse events associated with glucose-lowering drugs in patients with type 2 diabetes: a meta-analysis","volume":"316","author":"Palmer","year":"2016","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.ctim.2016.10.014_bib0110","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1027\/2151-2604\/a000176","article-title":"Antidepressants and the placebo effect","volume":"222","author":"Kirsch","year":"2014","journal-title":"Zeitschrift Fur Psychologie"},{"key":"10.1016\/j.ctim.2016.10.014_bib0115","first-page":"CD000448","article-title":"St John\u2019s wort for depression","volume":"2","author":"Linde","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"issue":"11","key":"10.1016\/j.ctim.2016.10.014_bib0120","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s10354-015-0372-7","article-title":"The mechanisms of action of St. John\u2019s wort: an update","volume":"165","author":"Schmidt","year":"2015","journal-title":"Wien Med Wochenschr"},{"issue":"6","key":"10.1016\/j.ctim.2016.10.014_bib0125","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/j.1751-1097.1995.tb09903.x","article-title":"Novel therapeutic and diagnostic applications of hypocrellins and hypericins","volume":"61","author":"Diwu","year":"1995","journal-title":"Photochem Photobiol"},{"issue":"9170","key":"10.1016\/j.ctim.2016.10.014_bib0130","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1016\/S0140-6736(99)00214-7","article-title":"Antibacterial activity of hyperforin from St John\u2019s wort, against multiresistant Staphylococcus aureus and gram-positive bacteria","volume":"353","author":"Schempp","year":"1999","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.ctim.2016.10.014_bib0135","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1211\/jpp.59.5.0011","article-title":"Topical anti-inflammatory activity of extracts and compounds from Hypericum perforatum L","volume":"59","author":"Sosa","year":"2007","journal-title":"J Pharm Pharmacol"},{"issue":"3\u20134","key":"10.1016\/j.ctim.2016.10.014_bib0140","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/BF03033510","article-title":"Quercetin, kaempferol and biapigenin from Hypericum perforatum are neuroprotective against excitotoxic insults","volume":"13","author":"Silva","year":"2008","journal-title":"Neurotox Res"},{"issue":"6","key":"10.1016\/j.ctim.2016.10.014_bib0145","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1211\/0022357991772862","article-title":"Effects of Hypericum perforatum on levels of 5-hydroxytryptamine: noradrenaline and dopamine in the cortex, diencephalon and brainstem of the rat","volume":"51","author":"Calapai","year":"1999","journal-title":"J Pharm Pharmacol"},{"issue":"16","key":"10.1016\/j.ctim.2016.10.014_bib0150","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1001\/archinte.160.16.2548-a","article-title":"Hyperforin in extracts of St John\u2019s wort (Hypericum perforatum) for depression","volume":"160","author":"Vormfelde","year":"2000","journal-title":"Arch Intern Med"},{"issue":"Suppl. 1","key":"10.1016\/j.ctim.2016.10.014_bib0155","doi-asserted-by":"crossref","first-page":"S98","DOI":"10.1055\/s-2001-15512","article-title":"Hyperforin\u2013antidepressant activity by a novel mechanism of action","volume":"34","author":"Muller","year":"2001","journal-title":"Pharmacopsychiatry"},{"issue":"3","key":"10.1016\/j.ctim.2016.10.014_bib0160","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/j.1527-3458.2004.tb00022.x","article-title":"Role of hyperforin in the pharmacological activities of St John's Wort","volume":"10","author":"Zanoli","year":"2004","journal-title":"CNS Drug Rev"},{"issue":"5","key":"10.1016\/j.ctim.2016.10.014_bib0165","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1211\/0022357011775910","article-title":"St John\u2019s wort (Hypericum perforatum L.): a review of its chemistry, pharmacology and clinical properties","volume":"53","author":"Barnes","year":"2001","journal-title":"J Pharm Pharmacol"},{"issue":"Suppl. 2","key":"10.1016\/j.ctim.2016.10.014_bib0170","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1055\/s-2007-979528","article-title":"Effects of hypericum extract (LI 160) in biochemical models of antidepressant activity","volume":"30","author":"Muller","year":"1997","journal-title":"Pharmacopsychiatry"},{"issue":"Suppl 1","key":"10.1016\/j.ctim.2016.10.014_bib0175","doi-asserted-by":"crossref","first-page":"S148","DOI":"10.1055\/s-2001-15465","article-title":"Evaluation of synaptosomal uptake inhibition of most relevant constituents of St. John's wort","volume":"34","author":"Wonnemann","year":"2001","journal-title":"Pharmacopsychiatry"},{"issue":"2","key":"10.1016\/j.ctim.2016.10.014_bib0180","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S1043-6618(02)00266-9","article-title":"Current St John\u2019s wort research from mode of action to clinical efficacy","volume":"47","author":"Muller","year":"2003","journal-title":"Pharmacol Res"},{"issue":"2","key":"10.1016\/j.ctim.2016.10.014_bib0185","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jpain.2009.06.013","article-title":"A prolonged protein kinase C-mediated, opioid-related antinociceptive effect of st John\u2019s Wort in mice","volume":"11","author":"Galeotti","year":"2010","journal-title":"J Pain"},{"issue":"9","key":"10.1016\/j.ctim.2016.10.014_bib0190","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/j.bcp.2009.12.016","article-title":"St. John\u2019s Wort reduces neuropathic pain through a hypericin-mediated inhibition of the protein kinase Cgamma and epsilon activity","volume":"79","author":"Galeotti","year":"2010","journal-title":"Biochem Pharmacol"},{"issue":"3","key":"10.1016\/j.ctim.2016.10.014_bib0195","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/j.1532-2149.2012.00196.x","article-title":"St. John's wort relieves pain in an animal model of migraine","volume":"17","author":"Galeotti","year":"2013","journal-title":"Eur J Pain"},{"issue":"8","key":"10.1016\/j.ctim.2016.10.014_bib0200","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s002280050519","article-title":"Adverse effects profile of the herbal antidepressant St. John\u2019s wort (Hypericum perforatum L.)","volume":"54","author":"Ernst","year":"1998","journal-title":"Eur J Clin Pharmacol"},{"issue":"5","key":"10.1016\/j.ctim.2016.10.014_bib0205","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1211\/0022357011775910","article-title":"St John\u2019s wort (Hypericum perforatum L.): a review of its chemistry, pharmacology and clinical properties","volume":"53","author":"Barnes","year":"2001","journal-title":"J Pharm Pharmacol"},{"issue":"4","key":"10.1016\/j.ctim.2016.10.014_bib0210","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1007\/s002130000625","article-title":"St. John\u2019s wort (Hypericum perforatum): a review of the current pharmacological, toxicological, and clinical literature","volume":"153","author":"Greeson","year":"2001","journal-title":"Psychopharmacology (Berl)"},{"issue":"3","key":"10.1016\/j.ctim.2016.10.014_bib0215","doi-asserted-by":"crossref","first-page":"139","DOI":"10.5414\/CPP42139","article-title":"Drug interactions with St. John\u2019s Wort (Hypericum perforatum): a review of the clinical evidence","volume":"42","author":"Izzo","year":"2004","journal-title":"Int J Clin Pharmacol Ther"},{"issue":"17","key":"10.1016\/j.ctim.2016.10.014_bib0220","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.2174\/138161208784746798","article-title":"Clinical drugs that interact with St. John\u2019s wort and implication in drug Development","volume":"14","author":"Di","year":"2008","journal-title":"Curr Pharm Des"},{"issue":"5","key":"10.1016\/j.ctim.2016.10.014_bib0225","doi-asserted-by":"crossref","first-page":"394","DOI":"10.2174\/138920008784746391","article-title":"An update on clinical drug interactions with the herbal antidepressant St. John\u2019s wort","volume":"9","author":"Zhou","year":"2008","journal-title":"Curr Drug Metab"},{"issue":"6","key":"10.1016\/j.ctim.2016.10.014_bib0230","doi-asserted-by":"crossref","first-page":"3540","DOI":"10.1007\/s12035-015-9292-1","article-title":"Hypericum perforatum attenuates spinal cord injury-induced oxidative stress and apoptosis in the dorsal root ganglion of rats: involvement of TRPM2 and TRPV1 channels","volume":"53","author":"\u00d6zdemir","year":"2016","journal-title":"Mol Neurobiol"},{"issue":"3","key":"10.1016\/j.ctim.2016.10.014_bib0235","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1089\/089771502753594936","article-title":"Enhanced survival and regeneration of axotomized retinal ganglion cells by a mixture of herbal extracts","volume":"19","author":"Cheung","year":"2002","journal-title":"J Neurotrauma"},{"key":"10.1016\/j.ctim.2016.10.014_bib0240","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.neuroscience.2014.01.006","article-title":"Modulation of oxidative stress and Ca(2+) mobilization through TRPM2 channels in rat dorsal root ganglion neuron by Hypericum perforatum","volume":"263","author":"Naziroglu","year":"2014","journal-title":"Neuroscience"}],"container-title":["Complementary Therapies in Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0965229916302795?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0965229916302795?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T17:05:36Z","timestamp":1760807136000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0965229916302795"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":48,"alternative-id":["S0965229916302795"],"URL":"https:\/\/doi.org\/10.1016\/j.ctim.2016.10.014","relation":{},"ISSN":["0965-2299"],"issn-type":[{"value":"0965-2299","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hypericum perforatum (St. John\u2019s Wort) as a possible therapeutic alternative for the management of trigeminal neuralgia (TN) \u2013 A case report","name":"articletitle","label":"Article Title"},{"value":"Complementary Therapies in Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctim.2016.10.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}